Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
Calquence approved in the EU for the treatment of chronic lymphocytic leukaemia
-
Brilinta approved in the US to reduce the risk of stroke in patients with an acute ischaemic stroke or high-risk transient ischaemic attack
-
Lynparza approved in the EU as 1st-line maintenance treatment with bevacizumab for HRD-positive advanced ovarian cancer
-
Lynparza approved in the EU for the treatment of BRCA-mutated metastatic castration-resistant prostate cancer
-
Forxiga approved in the EU for heart failure
-
Year-to-date and Q3 2020 results
-
Atacand to be divested to Cheplapharm in more than 70 countries
-
Fasenra eliminated oral corticosteroid use in a majority of OCS-dependent patients with asthma in PONENTE Phase IIIb trial
-
Enhertu granted Priority Review in the US for the treatment of HER2-positive metastatic gastric cancer
-
Forxiga cardiovascular outcomes benefit approved in China
Latest articles and press releases
All of our latest press releases and articles are available to explore
